Key result
PKCδ deficiency in mice increases white blood cells and platelets, accelerating recovery from thrombocytopenia.
Why the study?
Does Protein Kinase C δ (PKCδ) deficiency enhance megakaryopoiesis and recovery from thrombocytopenia in mice?
Does Protein Kinase C δ (PKCδ) deficiency enhance megakaryopoiesis and recovery from thrombocytopenia in mice?
PKCδ deficiency enhances megakaryopoiesis and accelerates recovery from thrombocytopenia, suggesting PKCδ as a potential therapeutic target for thrombocytopenia.
Answers are grounded in this paper and cite their sources.
May support PKCδ as a thrombocytopenia target in mice; leaves open human translation and should not change practice.
OBJECTIVE: We previously determined that protein kinase C δ (PKCδ) regulates platelet function. However, the function of PKCδ in megakaryopoiesis is unknown. APPROACH AND RESULTS: Using PKCδ(-/-) and wild-type littermate mice, we found that deficiency of PKCδ caused an increase in white blood cells and platelet counts, as well as in bone marrow and splenic megakaryocytes (P<0.05). Additionally, the megakaryocyte number and DNA content were enhanced in PKCδ(-/-) mouse bone marrow after culturing with exogenous thrombopoietin compared with wild-type (P<0.05). Importantly, thrombopoietin-induced signaling was also altered with PKCδ deletion because both extracellular signal-regulated kinase and Akt308 phosphorylation were heightened in PKCδ(-/-) megakaryocytes compared with wild-type. Finally, PKCδ(-/-) mice recovered faster and had a heightened rebound thrombocytosis after thrombocytopenic challenge. CONCLUSIONS: These data suggest that PKCδ is an important megakaryopoietic protein, which regulates signaling induced by thrombopoietin and represents a potential therapeutic target.
No takes yet. Share an insight, caveat, or question.
Kostyak et al. (2014) studied Thrombocytopenia. PKCδ deficiency vs. Wild-type littermate mice was evaluated on White blood cell and platelet counts, bone marrow and splenic megakaryocytes (p=<0.05). PKCδ deficiency in mice caused an increase in white blood cells, platelet counts, and megakaryocytes, and led to faster recovery from thrombocytopenic challenge compared with wild-type.
Synapse has enriched 10 related papers. Consider them for comparative context: